Cripto‐1 acts as a molecular bridge linking nodal to ALK4 via distinct structural domains
Protein Science · 2025-02 · 34 (2)
DOI: 10.1002/pro.70034 ↗At a glance
Journal article in Protein Science, published online on 2025-01-22. Written by Kit-Yee Chu and 6 co-authors. Institution: Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan, USA. Major MEDLINE topics: Nodal Protein, GPI-Linked Proteins, Activin Receptors, Type I, Neoplasm Proteins. Cited 4 times so far (Crossref); 43 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (original language)
The TGF‐ β family ligand Nodal is an essential regulator of embryonic development, orchestrating key processes such as germ layer specification and body axis formation through activation of SMAD2/3‐mediated signaling. Significantly, this activation requires the co‐receptor Cripto‐1. However, despite their essential roles in embryogenesis, the molecular mechanism through which Cripto‐1 enables Nodal to activate the SMAD2/3 pathway has remained elusive. Intriguingly, Cripto‐1 also has been shown to antagonize other TGF‐ β family ligands, raising questions about its diverse functions. To clarify how Cripto‐1 modulates TGF‐ β signaling, we integrated AlphaFold3 modeling, surface plasmon resonance (SPR)‐based protein–protein interaction analysis, domain‐specific anti‐Cripto‐1 antibodies, and functional studies in NTERA‐2 cells. In contrast to canonical TGF‐ β signaling, where ligands bridge type I and type II receptors for activation, Nodal, bound to the type II receptor, utilizes Cripto‐1 to recruit the type I receptor ALK4, forming a unique ternary complex for SMAD2/3 activation. Our molecular characterization of Cripto‐1‐mediated Nodal signaling clarifies the unique role of this enigmatic co‐receptor and advances our understanding of signaling regulation within the TGF‐ β family. These insights have potential implications for both developmental biology and cancer research.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan, USA.
- Department of Structural Biology, Van Andel Institute, Grand Rapids, Michigan, USA.
ORCID profiles: Erik Martinez-Hackert
Funding
- NIGMS NIH HHS
- National Institute of General Medical Sciences
Cite
APA
Chu, K. Y., Crawford, A. N., Krah, B. S., Thamilselvan, V., Malik, A., Aitas, N. A., & Martinez-Hackert, E. (2025). Cripto‐1 acts as a molecular bridge linking nodal to ALK4 via distinct structural domains. Protein Science, 34(2). https://doi.org/10.1002/pro.70034
Vancouver
Chu KY, Crawford AN, Krah BS, Thamilselvan V, Malik A, Aitas NA, et al. Cripto‐1 acts as a molecular bridge linking nodal to ALK4 via distinct structural domains. Protein Science. 2025;34(2). doi:10.1002/pro.70034
BibTeX
@article{Chu2025,
author = {Chu, Kit-Yee and Crawford, Amberly N and Krah, Bradon S and Thamilselvan, Vijayalakshmi and Malik, Anjali and Aitas, Nina A and Martinez-Hackert, Erik},
title = {Cripto‐1 acts as a molecular bridge linking nodal to ALK4 via distinct structural domains},
journal = {Protein Science},
year = {2025},
volume = {34},
number = {2},
doi = {10.1002/pro.70034}
}
EUVIMED